About

Dr. Prasad Patki is a leading urologic surgeon and researcher whose work centers on advancing minimally invasive treatments for kidney cancer, with a particular focus on robot-assisted surgery and nephron-sparing approaches. His most impactful contribution is the landmark 2013 study comparing transperitoneal and retroperitoneal robot-assisted partial nephrectomy (RAPN), which has garnered 78 citations and established foundational evidence for surgical approach selection. Dr. Patki is also the driving force behind the NEST trial (Nephron Sparing Treatment for Small Renal Masses), a pioneering cohort-embedded randomized controlled trial comparing percutaneous cryoablation to RAPN, addressing a critical evidence gap in small renal mass management. His work extends to challenging anatomical scenarios, including safety and feasibility studies of robot-assisted surgery in horseshoe kidneys and the use of interactive virtual 3D image reconstruction for complex renal anomalies. With a portfolio spanning over 160 citations, Dr. Patki has also contributed to perioperative safety through crisis simulation models for robotic teams and early mitomycin C instillation after nephroureterectomy. His research directly informs clinical practice, balancing oncologic efficacy with functional preservation.

Research Focus

Key Achievements

6
H-Index
11
Papers
163
Total Citations
15
Avg Citations/Paper
🏆 Most Cited Paper
Robot-Assisted Partial Nephrectomy: A Comparison of the Transperitoneal and Retroperitoneal Approaches
78 citations · 2013
📈 Most Prolific Year: 2023 (3 Papers)
🤝 Key Collaborators: 67
🏛 Institutions: Queen Mary University of London, The Royal Free Hospital, Royal Free London NHS Foundation Trust, University College London Hospitals NHS Foundation Trust, Barts Health NHS Trust

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago